trial

In-person vs. Remote Wellness Support

NCTId NCT04526067
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 56 (actual)
Sponsored by The University of Texas Health Science Center at San Antonio
Primary completion 2022-11-11
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
56 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
Single
Start
2020-11-24
Primary completion
2022-11-11
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
CATR-CAT

Sponsors

The University of Texas Health Science Center at San AntonioLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Dawn I. Velligan, PhDPrincipal Investigator

Sites

1 total
San Antonio, United States

Facts & assertions

4 sourced
Enrollment
56
Phase
NA
Primary Completion Date
2022-11-11
Status
COMPLETED
relationships
The graph out of here
drug
CAT
drug
R-CAT
drug
lead_sponsor
The University of Texas Health Science Center at San Antonio
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizo Affective Disorder
indication
Bipolar Disorder
indication
Depressive Disorder, Major
indication
investigator
Dawn I. Velligan, PhD
person